Gene therapy stories
AI transforms cell & gene therapy manufacturing with real-time insights
Wed, 24th Sep 2025
#
gene therapy
AI-driven real-time monitoring in cell and gene therapy manufacturing cuts costs, improves quality, and speeds patient access to advanced treatments globally.
Viral vector facility selects SYSPRO Cloud ERP for compliance
Tue, 29th Apr 2025
#
gene therapy
Australia’s first viral vector manufacturing firm, VVMF, adopts SYSPRO Cloud ERP to enhance operations in advancing cell and gene therapies at Westmead Precinct.
Fuse Vectors secures USD $5.2m for gene therapy tech
Wed, 26th Feb 2025
#
gene therapy
Danish biotech firm Fuse Vectors has secured USD $5.2 million in pre-seed funding to advance its innovative cell-free gene therapy technology.
Peptide APIs drive growth in targeted therapy market
Thu, 30th Jan 2025
#
gene therapy
The peptide Active Pharmaceutical Ingredient market is poised for significant growth, driven by demand for targeted therapies and advances in synthesis technology.
Honeywell tech powers Peter Mac's AUD $105m cell and gene therapy manufacturing facility
Fri, 6th Sep 2024
#
gene therapy
Honeywell supports Peter Mac’s AUD $105M Melbourne facility, Australia’s first to commercialise CAR T-cell therapies, with advanced building tech.